Briggs, M
R.ManchandraP.et al (2024)
Authoritative External References DailyMed: EGRIFTA SV (tesamorelin) label, Sections 11 (Description) and 12.1 (Mechanism of Action) FDA Global Substance Registration System: Tesamorelin substance record PubChem: Tesamorelin, CID 16137828 PubChem: Ipamorelin, CID 9831659 Mayo KE, Miller TL, DeAlmeida V, Zheng J, Godfrey PA
PubMed Portnoi G, Chng LA, Karimi-Tabesh L, et al
What To Avoid: As with the other injection sites, avoid skin that contains tattoos, scars, bruising, or stretch marks